What's more, SRXN1 overexpression presented good power of predicting the outcomes of HCC patients, even patients with alcohol consumption and hepatitis virus infection, or patients with advanced clinicopathological parameters, using samples from both public databases and Zhongshan Hospital. This evidence concerns the gene SRXN1 and hepatocellular carcinoma.